Moxibustion
Moxibustion (moxa therapy; Chinese jiu)
Evidence grade varies by use. See the breakdown on the entry. Read how the Atlas grades evidence.
Evidence is honest-2 overall and uneven across uses. The strongest case is breech presentation. A 2023 Cochrane review (Coyle and colleagues, 13 studies, 2,181 women) reported that moxibustion added to usual care probably reduces non-cephalic presentations at birth, which the reviewers rated moderate-certainty, and a 2021 meta-analysis in Healthcare (16 RCTs, 2,555 participants) reported a risk ratio of about 1.39 for cephalic presentation, with the authors noting the combined moxibustion-plus-acupuncture approach performed better than moxa alone. Even here, the reviewers describe heterogeneity as moderate to high, note that several trials carry bias risk, and observe that effects are larger in Asian-population studies, so they stop short of unqualified recommendation. For most other promoted indications (ulcerative colitis, chronic pain, prostatitis, fatigue) the trial base is small and methodologically weak, and reviewers conclude firm conclusions are not yet possible. Practitioners typically apply breech treatment around gestational weeks 28 to 35, 15 to 20 minutes per session over 7 to 14 days.
Reference only. Not medical advice.
| Treatment | Grade | Notes |
|---|---|---|
| Breech presentation (cephalic version, with BL67) | 3 of 5 | 2023 Cochrane (13 studies, 2,181 women): reviewers report moxibustion plus usual care probably reduces non-cephalic presentations, rated moderate-certainty; reviewers note the effect is strongest when paired with acupuncture. |
| Labor support (reduced oxytocin need) | 2 of 5 | Same Cochrane review reported moxibustion plus usual care probably reduces oxytocin use, but on fewer data and as a secondary outcome. |
| Ulcerative colitis | 1 of 5 | Multiple small RCTs of low methodological quality; reviewers state sample sizes and quality are too low for firm conclusions. |
| Chronic pain / prostatitis / general use | 1 of 5 | Promoted broadly in practice, but reviewers describe trials as small, heterogeneous, and at high risk of bias; theory outpaces controlled evidence. |
What can go wrong
The most common adverse event reported is burns, ranging from minor blistering to scarring, especially with direct (scarring) moxa; allergy, infection, and hyperpigmentation are also reported. Moxa combustion produces smoke that can raise indoor carbon monoxide and particulate levels well above ambient, causing coughing, dry throat, dizziness, and headache, with rare carbon monoxide poisoning in poorly ventilated rooms; chronic smoke exposure is an occupational concern for practitioners. In pregnancy, reported events include abdominal pain, unpleasant odor with nausea, and isolated reports of premature rupture of membranes or bleeding; breech treatment should be done under qualified obstetric and practitioner supervision with fetal monitoring, not self-directed.
This is something to take to a clinician. The Atlas can tell you what is known about moxibustion in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Moxibustion is the burning of dried, processed mugwort ("moxa") on or just above the skin to deliver heat to a chosen point on the body. It is among the oldest therapies of Chinese medicine, documented in the Mawangdui silk manuscripts sealed in 168 BCE before acupuncture was fully systematized, and it spread to Korea, Japan (as kyu), and Southeast Asia. Practitioners apply it in direct forms (a small cone burned on the skin, sometimes to blistering) and indirect forms (a moxa stick or cone held at a distance, or separated from the skin by ginger, salt, or garlic). Within the Enel library, moxibustion is unusual: it is a broadly promoted general-purpose warming therapy whose evidence is thin for most claims, but it has one pocket of moderate-certainty trial support. Reviewers report that heating the BL67 point at the outer corner of the fifth toenail around weeks 28 to 35 of pregnancy probably helps turn breech babies to a head-down position, an effect a 2023 Cochrane review rated moderate-certainty when moxa is added to usual care, and stronger still when combined with acupuncture. That signal sits alongside real, documented safety considerations: burns, smoke, and carbon monoxide.
Smoldering mugwort held over a point on the little toe. This is the one corner of an ancient Chinese fire therapy where modern trials report a signal: turning breech babies head-down.
How it is supposed to work
Established mechanism: moxibustion delivers focused radiant and conductive heat (and, in direct forms, a mild controlled burn) to a defined skin location, producing local vasodilation, warmth, and a counter-irritant sensory stimulus. For the breech indication specifically, the leading testable proposal advanced by trialists is that heating the Bladder-67 (BL67, Zhiyin) point at the outer corner of the fifth toenail raises maternal cortisol and prostaglandins and increases fetal movement, making spontaneous turning more likely; researchers report that fetal activity increases have been observed during treatment, though the causal chain to version is not established. Proposed/claimed mechanism (traditional framework, not established physiology): practitioners describe moxa as warming and moving qi and blood, expelling "cold" and "damp," and tonifying yang along specific meridians. The meridian-and-qi account is a traditional explanatory model and is not a verified physiological pathway.
What people get wrong
Often saidMoxibustion is a proven all-purpose treatment for pain, digestion, fatigue, and immunity.
ActuallyFor most of these the trials are small and low-quality; reviewers say firm conclusions are not yet possible. The one moderate-certainty signal reviewers identify is breech version.
Often saidMoxa is gentle heat with no real risks.
ActuallyBurns are the most reported adverse event, and combustion smoke can raise indoor carbon monoxide and particulates, with rare poisoning in unventilated spaces.
Who profits, and who pushes back
Cochrane Pregnancy and Childbirth review authors (Coyle, Smith, Peat)
Moxibustion combined with usual care probably reduces non-cephalic presentations at birth, but the certainty is moderate and the effect is clearest alongside acupuncture, not for moxa applied alone.
Practitioner-led moxibustion-for-breech clinics
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Providers describe home moxa at the little-toe point from around 34 weeks as a low-cost way to encourage a breech baby to turn before a planned cesarean is scheduled.
Xu and colleagues, moxibustion safety review
Across reported cases the adverse events include burns, allergy, infection, and, rarely, more serious harm; safety depends heavily on technique, ventilation, and practitioner skill.
Evidence-based obstetrics commentators
The breech data are encouraging enough to discuss as an adjunct, but external cephalic version remains the better-validated option and moxa should not replace obstetric monitoring.
Where the research comes from
Most of the published research on this comes from one place. 95% of it is from China. Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| China | 95% |
| Japan | 78% |
| Korea | 72% |
| Western Europe | 34% |
| North America | 30% |
How we got here
Moxibustion is one of the oldest documented therapies of Chinese medicine, and the written record places it in China before acupuncture was systematized. Silk manuscripts recovered from the Mawangdui tombs at Changsha, Hunan, sealed in 168 BCE, include the Zubi Shiyi Mai Jiujing and the Yinyang Shiyi Mai Jiujing, the "Moxibustion Canons of the Eleven Vessels," which prescribe burning treatment along vessels and contain no mention of needles or acupoints. Some scholars read Shang-dynasty oracle bone inscriptions (roughly 1600 to 1046 BCE) as early references to cauterizing therapy. The Huangdi Neijing ("Yellow Emperor's Inner Canon," compiled around the 2nd century BCE) later paired moxa with acupuncture and gave the rationale that conditions needles cannot reach, fire can. From China the practice spread to Korea and to Japan, where it is called kyu and developed distinctive direct and indirect techniques, and to Vietnam and across Southeast Asia.
The therapy's written history begins in China. The Mawangdui silk texts (168 BCE) describe moxibustion along eleven vessels with no reference to needling, and some scholars trace cauterizing therapy further back to Shang-dynasty oracle bones. The Huangdi Neijing (around the 2nd century BCE) integrated moxa with acupuncture and articulated its warming rationale. Over later dynasties Chinese physicians codified hundreds of moxa points and indications, and the practice was carried to Korea and to Japan, where Kampo and folk traditions refined direct "thread moxa" and indirect stick techniques. Western interest arrived comparatively late, the word "moxa" itself entering European languages through 17th-century Dutch and Portuguese reports from Japan. In the modern era the breech application drew clinical research attention after a 1998 JAMA randomized trial from Italy (Cardini and Weixin) reported increased fetal activity and cephalic version, prompting a still-active line of trials and Cochrane reviews from 2005 through 2023.
- c. 1600-1046 BCEPossible references to cauterizing therapy in Shang-dynasty oracle bone inscriptions, China
- 168 BCEMawangdui silk 'Moxibustion Canons of the Eleven Vessels' sealed in tomb; moxa described without needles
- c. 2nd century BCEHuangdi Neijing pairs moxa with acupuncture and states its warming rationale
- 1998Cardini and Weixin publish JAMA randomized trial on moxibustion at BL67 for breech version
- 2023Updated Cochrane review (Coyle et al., 13 studies) rates breech benefit moderate-certainty when added to usual care
How it is understood
Moxibustion remains a living, daily-use therapy across China, Japan, Korea, and the wider East Asian diaspora, taught in state-accredited TCM and Kampo curricula rather than confined to history. The herb itself, Artemisia argyi or Artemisia vulgaris mugwort, processed into "moxa floss," carries cultural weight beyond the clinic in several of these cultures.
Where scholars disagree
Moxibustion belongs to living Chinese, Japanese (kyu/Kampo), and Korean medical traditions still taught in state-accredited curricula. Its commercialization in Western "moxa-for-breech" clinics and consumer moxa products raises sovereignty questions about practitioner licensing, accurate attribution to East Asian medicine, and benefit-sharing, the same extraction concerns that attach to other commercialized East Asian therapies.
The clinical breech-version finding and its mechanism are separate claims with separate support. Trials report a moderate-certainty effect on fetal presentation, but the cause is contested: a physiological heat/hormonal model versus the traditional qi-and-meridian model, with neither established as the operative pathway.
Biomedical trialists and Cochrane reviewers
Any real effect on breech version is attributable to focal heat at BL67 acting through measurable physiology, proposed as raised maternal cortisol and prostaglandins and increased fetal movement, not through meridians.
What it rests onObservations of increased fetal activity during treatment and the 2023 Cochrane review's moderate-certainty effect; reviewers note the causal chain from heat to version is not established and heterogeneity is moderate to high.
Traditional East Asian medicine practitioners
Moxa at Zhiyin (BL67) works by warming and moving qi and blood and tonifying yang along the Bladder meridian, the framework in which the point was originally selected for breech.
What it rests onCenturies of documented use in Chinese, Japanese, and Korean texts and continuing clinical practice; the meridian-qi mechanism is a traditional explanatory model and is not a verified physiological pathway.
This disagreement is live. It has not settled.
At a glance
- Oldest written record
- Mawangdui silk 'Moxibustion Canons,' China, sealed 168 BCE, predate acupuncture systematization
- Herb used
- Processed mugwort (Artemisia argyi / vulgaris) 'moxa floss'
- Best-evidenced use
- Breech version at BL67 (Zhiyin), gestational weeks ~28-35
- Most common harm
- Burns; plus smoke and carbon monoxide in poorly ventilated rooms
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Moxibustion. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.